Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Vaccinations01:51

Vaccinations

52.2K
Overview
52.2K
Cross-reactivity00:42

Cross-reactivity

33.2K
Overview
33.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Choosing the Right Extracellular Vesicle: Cross-Kingdom Immunological Functions Linking Molecular Mechanisms to Therapeutic Applications.

Biomolecules·2026
Same author

A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains.

Bioorganic chemistry·2026
Same author

Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.

NPJ vaccines·2026
Same author

Veterinary Forensic Pathology in the Investigation of Animal Cruelty: Post-Mortem Insights, Forensic Tools, Case Studies, and Legal Perspectives.

Animals : an open access journal from MDPI·2026
Same author

The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics.

Veterinary sciences·2026
Same author

Development of a Novel Polyleucine-Based Immunopotentiator for Subunit Vaccines Against Group A Streptococcus.

Small (Weinheim an der Bergstrasse, Germany)·2026

Related Experiment Video

Updated: Feb 25, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K

Peptide-based synthetic vaccines.

Mariusz Skwarczynski1, Istvan Toth1,2,3

  • 1The University of Queensland , School of Chemistry and Molecular Biosciences , St Lucia 4072 , Australia .

Chemical Science
|August 10, 2017
PubMed
Summary
This summary is machine-generated.

Synthetic peptide vaccines offer advantages over traditional vaccines but face challenges with poor immune responses. Research explores epitope design, adjuvants, and nanoparticle approaches to enhance synthetic vaccine efficacy.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.1K

Related Experiment Videos

Last Updated: Feb 25, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

2.3K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.1K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.1K

Area of Science:

  • Immunology
  • Vaccinology
  • Biotechnology

Background:

  • Traditional vaccines utilize live or attenuated microorganisms, posing risks of impurities and redundant components.
  • Current limitations of traditional vaccines necessitate the development of safer and more effective alternatives.

Purpose of the Study:

  • To review the current status of peptide-based vaccines.
  • To discuss strategies for improving synthetic vaccine efficacy, including epitope and adjuvant design.
  • To explore multi-epitope and nanoparticle-based vaccine approaches.

Main Methods:

  • Literature review of peptide-based vaccine development.
  • Analysis of epitope and adjuvant design principles.
  • Discussion of multi-epitope and nanoparticle vaccine strategies.

Main Results:

  • Peptide-based vaccines can overcome traditional vaccine drawbacks but often elicit weak immune responses.
  • Adjuvants can enhance immune responses but may introduce new challenges.
  • Multi-epitope and nanoparticle-based approaches show promise for improving synthetic vaccine performance.

Conclusions:

  • Synthetic peptide vaccines represent a promising alternative to traditional vaccines.
  • Further research into epitope optimization, adjuvant selection, and novel delivery systems is crucial for advancing synthetic vaccine technology.
  • Addressing the challenges of weak immunogenicity is key to realizing the full potential of peptide-based vaccines.